Paul Paradiso

Paul Paradiso practices at Texas Health Surgery Center Rockwall in Rockwall, Texas.

Paul Paradiso's NPI, 1861836108, was assigned on April 17, 2013. Paul Paradiso graduated from Texas College of Osteopathic Medicine in 2013. Paul Paradiso holds Texas license S0352.

Paul Paradiso's primary practice is Texas Health Surgery Center Rockwall, at 3144 Horizon Road Ste 120, Rockwall, TX 75032. The practice phone is (972) 845-1469.

Paul Paradiso's primary practice is Texas Health Surgery Center Rockwall in Rockwall, Texas. Paul Paradiso is also affiliated with Texas Health Hospital Rockwall. The medical group on file is Texas Digestive Disease Consultants. Dmand AI also links Paul Paradiso to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Paul Paradiso practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Paul Paradiso's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Paul Paradiso is board certified in gastroenterology by the American Board of Internal Medicine. Paul Paradiso is licensed in Texas.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Paul Paradiso treats.

CMS data shows 2,024 Medicare services from Paul Paradiso across 15 procedure codes in 2024, for 339 Medicare patients. Medicare paid $93,428 for them.

CMS counts 339 Medicare patients who saw Paul Paradiso in 2024. The largest group is 65 to 74, with 171 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Paul Paradiso's median patient age at 58, with 54% women.

In 2024, Paul Paradiso wrote 651 Medicare Part D claims for 332 patients. 69% of them were for generic drugs. CMS names the drug for 521 of them, across 13 drugs with 11 or more claims each, at $108,124 in total drug cost. In 2023, CMS named 323 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Paul Paradiso for performance year 2024, reported as part of a group. Paul Paradiso accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 122 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Paul Paradiso, more than 81% of the clinicians it reports for that procedure.

CMS Open Payments shows 448 general payments to Paul Paradiso from 31 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $3,593.

Paul Paradiso graduated from Texas College of Osteopathic Medicine in 2013.

Paul Paradiso is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.